Hall Laurie J Trustee Cytokinetics Inc Transaction History

Hall Laurie J Trustee

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$35.77 - $51.11 $2,325 - $3,322	-65 Reduced 38.24%	105 $5,000
Q3 2022 Oct 11, 2022	SELL	$38.54 - $54.52 $3,083 - $4,361	-80 Reduced 32.0%	170 $8,000
Q1 2022 Apr 06, 2022	BUY	$29.74 - $46.0 $297 - $460	10 Added 4.17%	250 $9,000
Q3 2021 Oct 04, 2021	SELL	$18.54 - $35.74 $2,781 - $5,361	-150 Reduced 38.46%	240 $9,000
Q3 2020 Oct 09, 2020	BUY	$20.58 - $28.96 $2,469 - $3,475	120 Added 44.44%	390 $8,000
Q4 2019 Feb 12, 2020	BUY	$7.95 - $11.84 $397 - $592	50 Added 22.73%	270 $3,000
Q4 2018 Feb 14, 2019	SELL	$5.91 - $9.29 $295 - $464	-50 Reduced 18.52%	220 $2,000
Q4 2017 Jan 30, 2018	SELL	$7.25 - $15.65 $870 - $1,878	-120 Reduced 30.77%	270 $2,000
Q3 2017 Oct 02, 2017	BUY	$12.0 - $15.0 $4,680 - $5,850	390	390 $0

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.61B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.